Morgan Stanley analyst Craig Hettenbach says the firm’s latest checks point to better-than-expected growth in calendar Q3 and positive sentiment toward a calendar Q4 budget flush, with Doximity’s (DOCS) video modules the driving force behind a reacceleration in its growth, consistent with prior checks. The firm, which adds that it finds “no impact” and no overlap with OpenEvidence to date, has an Equal-weight rating and $62 price target on Doximity shares.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCS:
- The S&P 500 Might Be Overheated, but Bank of America Sees Value in These 2 Stocks
- Doximity upgraded to Buy from Neutral at BofA
- Private Markets: Crusoe raises $1.375B at valuation above $10B
- Buy/Sell: Wall Street’s top 10 stock calls this week
- Midday Fly By: Trump threatens China tariffs, Kalshi valued at $5B